- Home
- SSYS vs MYGN Comparison
SSYS vs MYGN Comparison
Compare SSYS & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSYS
- MYGN
- Stock Information
- Founded
- SSYS 1989
- MYGN 1991
- Country
- SSYS United States
- MYGN United States
- Employees
- SSYS N/A
- MYGN N/A
- Industry
- SSYS Computer peripheral equipment
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SSYS Technology
- MYGN Health Care
- Exchange
- SSYS Nasdaq
- MYGN Nasdaq
- Market Cap
- SSYS 857.2M
- MYGN 744.7M
- IPO Year
- SSYS 1994
- MYGN 1995
- Fundamental
- Price
- SSYS $10.37
- MYGN $4.92
- Analyst Decision
- SSYS Strong Buy
- MYGN Hold
- Analyst Count
- SSYS 4
- MYGN 15
- Target Price
- SSYS $12.50
- MYGN $15.14
- AVG Volume (30 Days)
- SSYS 377.0K
- MYGN 2.1M
- Earning Date
- SSYS 05-08-2025
- MYGN 08-05-2025
- Dividend Yield
- SSYS N/A
- MYGN N/A
- EPS Growth
- SSYS N/A
- MYGN N/A
- EPS
- SSYS N/A
- MYGN N/A
- Revenue
- SSYS $564,454,000.00
- MYGN $831,300,000.00
- Revenue This Year
- SSYS $2.01
- MYGN N/A
- Revenue Next Year
- SSYS $4.01
- MYGN $6.68
- P/E Ratio
- SSYS N/A
- MYGN N/A
- Revenue Growth
- SSYS N/A
- MYGN 7.38
- 52 Week Low
- SSYS $6.05
- MYGN $3.81
- 52 Week High
- SSYS $12.88
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- SSYS 48.40
- MYGN 46.03
- Support Level
- SSYS $10.06
- MYGN $4.78
- Resistance Level
- SSYS $10.82
- MYGN $5.29
- Average True Range (ATR)
- SSYS 0.30
- MYGN 0.32
- MACD
- SSYS -0.03
- MYGN 0.11
- Stochastic Oscillator
- SSYS 44.66
- MYGN 60.98
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.